Written by the Nuvirox Research Team
Key Points
- A newly presented 2026 randomized trial (218 adults, conference abstract, not yet peer-reviewed) found reishi mushroom extract reduced insomnia severity more than melatonin over eight weeks.
- Older, smaller human trials support reishi's role in fatigue and stress reduction, with sleep quality typically a secondary rather than primary outcome.
- The strongest reishi finding to date is a single conference abstract; treat it as a promising early signal, not settled science, until it's published and replicated.
Short answer: reishi mushroom has a genuinely exciting new trial behind it, but that trial is still a conference abstract rather than a peer-reviewed publication, so "can it outperform melatonin" is currently a promising early finding, not an established fact. The mechanistic and secondary-outcome data supporting reishi's calming effects is older and more modest.
What is reishi mushroom, and why sleep?
Reishi (Ganoderma lucidum) is a mushroom used for centuries in East Asian traditional medicine, valued for its bioactive triterpenes and polysaccharides. The proposed sleep mechanism involves modulation of GABAergic neurotransmission and broader regulation of neurotransmitter balance, alongside anti-inflammatory and immune-modulating effects that may indirectly support recovery and rest.
What did the new 2026 trial find?
The headline data point driving current interest in reishi for sleep comes from a late-breaking abstract presented at the SLEEP 2026 annual meeting in Baltimore. In an eight-week, randomized, parallel-group trial of 218 adults with chronic insomnia, participants received either 5 mg of melatonin nightly or 980 mg of reishi mushroom extract standardized to 6% triterpenes. The primary outcome, change in Insomnia Severity Index score, dropped by an average of 8.7 points in the reishi group versus 5.6 points in the melatonin group — a statistically significant between-group difference that held up after adjusting for age, sex, and baseline severity. Completion was high (95.9%) and no serious adverse events were reported.
This is a genuinely interesting result, and we want to be direct about exactly how much weight it can currently bear: it is a single trial, presented as a conference abstract rather than published in a peer-reviewed journal, which means it hasn't yet been through full independent scrutiny of its methods and data. Conference abstracts sometimes hold up on publication and sometimes don't. The honest posture here is cautious optimism, not "reishi beats melatonin, full stop."
What does the older, peer-reviewed evidence show?
Outside of the new headline trial, reishi's human evidence base for sleep specifically is thinner and mostly indirect. A randomized, double-blind, placebo-controlled trial of 132 adults with neurasthenia (a condition marked by fatigue, poor rest, and low resilience) found that a standardized reishi polysaccharide extract improved clinician-rated well-being and reduced fatigue more than placebo over eight weeks — but sleep specifically wasn't the primary outcome, even though non-restorative sleep is part of the neurasthenia symptom cluster. A more recent randomized, double-blind, placebo-controlled trial testing a blend of reishi, cordyceps, and lion's mane mushrooms in young adults found modest improvements in sleep, mood, and stress markers, though as a multi-mushroom blend it can't isolate reishi's individual contribution.
A separate crossover trial in men with Gulf War Illness tested reishi against placebo for general symptom severity and found no significant improvement at a lower dose, and worse symptoms at a higher dose — a useful reminder that reishi's effects aren't uniformly positive across every population and dose tested.
Study Snapshot: SLEEP 2026 reishi vs. melatonin abstract
| Design | Randomized, parallel-group, 8-week trial (conference abstract) |
| Participants | 218 adults with chronic insomnia (209 completed) |
| Comparator | Melatonin 5 mg nightly vs. reishi extract 980 mg (6% triterpenes) |
| Result | ISI dropped 8.7 pts (reishi) vs. 5.6 pts (melatonin); no serious adverse events |
| Caveat | Not yet peer-reviewed; single trial, needs independent replication |
How does reishi compare to other adaptogenic mushrooms marketed for sleep?
Reishi is often sold alongside or blended with other "functional mushrooms" — lion's mane, cordyceps, chaga — under a broad adaptogen umbrella similar in spirit to how botanicals like magnolia bark and holy basil get marketed, and it's worth separating the marketing category from the evidence. Of the mushrooms commonly stacked into sleep gummies and blends, reishi has the most direct sleep-specific trial data of the group, including the new SLEEP 2026 abstract. Lion's mane and cordyceps have their own separate research bases, mostly focused on cognition and exercise performance rather than sleep, and including them in a blend makes it harder to know how much of any observed benefit is coming from reishi specifically versus the other mushrooms along for the ride. If sleep is your specific goal, a reishi-forward product with a stated triterpene percentage is a more evidence-aligned choice than a "mushroom complex" that lists reishi as one ingredient among five. For a related gut-linked mechanism, our gut microbiome and sleep review covers some of the overlapping territory these mushroom blends often invoke.
What reishi mushroom won't do
Even taking the new trial at face value, reishi hasn't been tested across the range of populations, doses, and durations that melatonin has accumulated over decades of research. If you have a bleeding disorder or take blood thinners, reishi has documented anticoagulant and antiplatelet properties in some research and should be used only with medical guidance. It is not a substitute for treatment of a diagnosed sleep disorder.
Dosing and safety
The SLEEP 2026 trial used 980 mg of extract standardized to 6% triterpenes. The neurasthenia trial used a standardized polysaccharide extract at a different dose over eight weeks. As with any new supplement, start with the lowest effective labeled dose and watch for gastrointestinal upset, which is the most commonly reported side effect across reishi trials.
Frequently asked questions
Is the reishi vs. melatonin study peer-reviewed?
Not yet. As of this writing, it's a late-breaking abstract presented at the SLEEP 2026 annual meeting rather than a published, peer-reviewed paper. That doesn't mean it's wrong, but it does mean it hasn't been through the same level of independent scrutiny as an established, published trial.
Can reishi replace melatonin?
Based on one preliminary trial, it's plausible reishi could be a helpful alternative for some people, but this needs replication in published, peer-reviewed research before it can be called a settled recommendation.
Does reishi interact with blood thinners?
Reishi has shown antiplatelet and anticoagulant activity in some research, so combining it with blood-thinning medication should only be done with a doctor's guidance.
From Nuvirox
Why we formulated Sleep+ Restore
Sleep+ Restore combines melatonin with St. John’s Wort and 5-HTP in a single nightly formula, designed for people whose sleep trouble is tangled up with a low, unsettled mood rather than a purely mechanical sleep-hygiene problem.
Learn more about Sleep+ Restore →Backed by a 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.
The bottom line
Reishi mushroom just had its best sleep-specific trial result yet — an eight-week study suggesting it may outperform melatonin — but that finding is still a conference abstract awaiting peer review and independent replication. It's a genuinely promising early signal on top of a smaller, older base of fatigue and stress research, not yet a settled substitute for melatonin.
References
- Xie C. Can’t sleep? Comparing reishi mushroom versus melatonin for chronic insomnia. Late-breaking abstract presented at SLEEP 2026 annual meeting, Baltimore, MD, June 2026 (n=218 randomized, 8-week trial; conference abstract, not yet peer-reviewed).
- Hisamuddin ASD, et al. Adaptogenic effects of mushroom blend supplementation on stress, fatigue, and sleep: a randomised, double-blind, placebo-controlled trial. Brain Behav. 2026. DOI: 10.1002/brb3.71193.
- Reishi polysaccharide extract randomized, double-blind, placebo-controlled trial in 132 adults with neurasthenia showed improved clinician-rated well-being and reduced fatigue versus placebo over 8 weeks (symptom cluster includes non-restorative sleep; sleep was not the primary outcome).
- Younger J, Donovan EK, Hodgin KS, Ness TJ. A placebo-controlled, pseudo-randomized, crossover trial of botanical agents for Gulf War Illness: reishi mushroom, stinging nettle, and epimedium. Int J Environ Res Public Health. 2021;18(7):3671.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.